Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,147 | 463 | 99.3% |
| Education | $52.09 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $994.54 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $979.09 | 63 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $967.19 | 65 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $888.82 | 61 | $0 (2023) |
| Abbott Laboratories | $603.52 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $465.60 | 36 | $0 (2024) |
| ABBVIE INC. | $361.74 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $302.58 | 20 | $0 (2024) |
| Novo Nordisk Inc | $218.43 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $139.99 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $653.31 | 32 | Abbott Laboratories ($172.34) |
| 2023 | $818.59 | 50 | Lilly USA, LLC ($287.16) |
| 2022 | $998.53 | 63 | Lilly USA, LLC ($281.12) |
| 2021 | $946.53 | 65 | SANOFI-AVENTIS U.S. LLC ($155.72) |
| 2020 | $597.37 | 38 | AstraZeneca Pharmaceuticals LP ($121.88) |
| 2019 | $827.13 | 59 | AstraZeneca Pharmaceuticals LP ($229.27) |
| 2018 | $1,074 | 73 | AstraZeneca Pharmaceuticals LP ($202.80) |
| 2017 | $1,283 | 89 | Boehringer Ingelheim Pharmaceuticals, Inc. ($259.81) |
All Payment Transactions
469 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Diabetes Care | ||||||
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Diabetes Care | ||||||
| 11/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.11 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: Insulin Pump | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Diabetes Care | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: DIABETES | ||||||
| 07/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Gastroenterology | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes Care | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Diabetes Care | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Gastroenterology | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 916 | 1,455 | $195,335 | $64,563 |
| 2022 | 20 | 965 | 1,399 | $183,712 | $57,518 |
| 2021 | 22 | 1,098 | 1,524 | $174,546 | $61,338 |
| 2020 | 21 | 1,157 | 1,577 | $185,910 | $60,834 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 363 | $90,750 | $27,837 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 207 | $36,225 | $10,543 | 29.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 118 | 121 | $14,520 | $8,683 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 35 | $11,200 | $4,262 | 38.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 122 | 125 | $6,250 | $3,670 | 58.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 27 | 31 | $7,750 | $2,706 | 34.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $4,654 | $1,998 | 42.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 20 | 27 | $3,596 | $1,362 | 37.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 21 | 24 | $3,840 | $1,004 | 26.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 60 | $3,600 | $785.22 | 21.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 31 | 49 | $2,450 | $605.15 | 24.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 72 | 72 | $1,440 | $308.88 | 21.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 13 | 50 | $600.00 | $205.80 | 34.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 30 | 57 | $1,140 | $182.97 | 16.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 16 | 16 | $2,600 | $174.71 | 6.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 35 | 178 | $4,450 | $142.06 | 3.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 27 | $270.00 | $92.07 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 285 | $71,244 | $21,377 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 147 | 203 | $35,529 | $10,147 | 28.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 135 | 136 | $16,320 | $9,246 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 135 | 137 | $12,820 | $3,793 | 29.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 30 | 41 | $10,065 | $3,184 | 31.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $3,690 | $2,237 | 60.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 18 | $5,760 | $2,126 | 36.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 27 | 37 | $4,992 | $1,519 | 30.4% |
About Dr. David Mesibov, MD
Dr. David Mesibov, MD is a Family Medicine healthcare provider based in Los Alamos, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912001520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mesibov, MD has received a total of $7,199 in payments from pharmaceutical and medical device companies, with $653.31 received in 2024. These payments were reported across 469 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,147).
As a Medicare-enrolled provider, Mesibov has provided services to 4,136 Medicare beneficiaries, totaling 5,955 services with total Medicare billing of $244,253. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Los Alamos, NM
- Active Since 09/12/2006
- Last Updated 08/07/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1912001520
Products in Payments
- JARDIANCE (Drug) $717.56
- FARXIGA (Drug) $617.80
- MOUNJARO (Drug) $427.21
- TRULICITY (Drug) $354.86
- FREESTYLE LIBRE 3 (Device) $320.73
- SOLIQUA 100/33 (Biological) $304.29
- TOUJEO (Drug) $276.00
- JANUVIA (Drug) $210.86
- SOLIQUA (Drug) $200.19
- XARELTO (Drug) $175.09
- VRAYLAR (Drug) $171.07
- ELIQUIS (Drug) $152.14
- XIFAXAN (Drug) $139.99
- SYMBICORT (Drug) $130.27
- INVOKANA (Drug) $127.49
- SPIRIVA RESPIMAT (Drug) $116.38
- UBRELVY (Drug) $113.92
- FREESTYLE LIBRE (Device) $113.43
- STIOLTO (Drug) $112.35
- Kerendia (Drug) $110.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Los Alamos
Bard Rogers, M.d, M.D
Family Medicine — Payments: $2,741
Dr. Elena Mcatee, M.d, M.D
Family Medicine — Payments: $558.76
Dr. Paul Daly, Md, MD
Family Medicine — Payments: $187.94
Michelle Carr, Md, MD
Family Medicine — Payments: $136.38
Pema Tamang, Fnp, FNP
Family Medicine — Payments: $109.61
Herbert Taylor, Md, MD
Family Medicine — Payments: $41.43